MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab

BACKGROUND: Targeted therapies directed at commonly overexpressed pathways in melanoma have clinical activity in numerous trials. Little is known about how these therapies influence microRNA (miRNA) expression, particularly with combination regimens. Knowledge of miRNAs altered with treatment may co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagenseller, Aubrey G, Shada, Amber, D’Auria, Kevin M, Murphy, Cheryl, Sun, Dandan, Molhoek, Kerrington R, Papin, Jason A, Dutta, Anindya, Slingluff Jr, Craig L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853033/
https://www.ncbi.nlm.nih.gov/pubmed/24047116
http://dx.doi.org/10.1186/1479-5876-11-218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853033/
https://www.ncbi.nlm.nih.gov/pubmed/24047116
http://dx.doi.org/10.1186/1479-5876-11-218

Ejemplares similares